Telomir Pharmaceuticals (TELO) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist

4.300
-0.250-5.49%

Close Jan 8 16:00 ET

4.300
0.0000.00%

Post 20:01 ET

127.32MMarket Cap-5.55P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Renovaro Names Nathen Fuentes as CFO
MT NewswiresJan 7 10:02 ET
Telomir Pharmaceuticals Shares Are Trading Higher After the Company Announced Potentially Groundbreaking Findings From a Preclinical Progeria Lifespan Study.
BenzingaJan 7 08:49 ET
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
AccesswireJan 7 08:00 ET
Express News | Telomir Pharmaceuticals: Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria
ReutersJan 7 07:33 ET
Express News | Telomir Pharmaceuticals Inc - to Submit Ind & Inad Application by Q4 2025, With Clinical Trials Planned for 2026
ReutersDec 23, 2024 07:04 ET
EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease
BenzingaDec 23, 2024 06:46 ET

Comments

Jaguar8

Yesterday 10:00

⚫️ Watchlist JANUARY 8,2025, Wednesday NFA

NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. NEVER be a blind follower.
LASTLY, If y...

Teddy123

Yesterday 00:12

Biotech investment analysis

$Telomir Pharmaceuticals (TELO.US)$
From an investment perspective, these preclinical results substantially enhance TELO's value proposition. With a market cap of just $135M, the company appears undervalued given the broad therapeutic potential of Telomir-1. The addressable market spans rare diseases like progeria (~400 patients globally) to massive markets like Type 2 diabetes, creating a compelling risk-reward profile.
The metal ion regulation mechanism is particular...

Teddy123

Jan 7 07:39

Positive medical research analysis

$Telomir Pharmaceuticals (TELO.US)$
The preclinical study results for Telomir-1 represent a significant scientific breakthrough in addressing accelerated aging conditions. The restoration of lifespan in wrn-1-mutated C. elegans to normal levels demonstrates robust proof-of-concept for Telomir-1's mechanism of action. The normalization of physiological parameters like movement velocity provides tangible evidence of improved healthspan, not just lifespan.
The comp...

Jaguar8

Jan 7 07:04

NEWS

$Telomir Pharmaceuticals (TELO.US)$
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
Tuesday, 7th January at 8:00 am
MIAMI, FL / ACCESSWIRE / January 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) ("Telomir"), an emerging leader in age-reversal science focused on treating the root causes of diseases rather than just their symptoms, announced today potentially grou...

Jaguar8

Dec 23, 2024 06:31

NEWS

$Telomir Pharmaceuticals (TELO.US)$
Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease
Monday, 23rd December at 7:30 am
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), or the "Company", an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is a promising development as the company explores Telomir-1 for the...

Heat List

Overall

No Data